Jamieson Wellness (JWEL) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Revenue grew 17.4% year-over-year to $233.8 million, with Jamieson Brands up 18.6% and Strategic Partners up 8.3%.
Net earnings reached $18.6 million, and adjusted net earnings were $19.9 million, up $2.7 million year-over-year.
Announced agreement to be acquired by Kirin Holdings at CAD $45.75 per share, prompting withdrawal of 2026 financial guidance.
Dividend increased by 8.7% to $0.25 per share, payable September 15, 2026.
Financial highlights
Gross profit rose by $16.6 million to $97.4 million; normalized gross profit margin increased by 160 bps.
EBITDA increased by $8.3 million to $38.4 million; adjusted EBITDA up 12.3% to $39.4 million.
Diluted EPS was $0.42; adjusted diluted EPS was $0.46.
Operating margin improved to 12.7% from 11.7% year-over-year.
Outlook and guidance
Withdrew previously issued 2026 guidance due to pending acquisition by Kirin and related uncertainties.
Latest events from Jamieson Wellness
- 2026 revenue guidance of $895M–$935M CAD driven by global expansion and strong brand leadership.JWEL
Investor presentation - Q1 revenue up 16.3%, China up 55%, margins expanded, and 2026 outlook reaffirmed.JWEL
Q1 2026 - Branded revenue up 16%, China drives growth; 2026 outlook targets double-digit expansion.JWEL
Q4 2025 - Q2 revenue up 7.7%, China sales surged 71%, margins and 2025 guidance improved, dividend up 9.5%.JWEL
Q2 2025 - Q3 revenue up 16.3% to $176.2M, with record China growth and improved margins.JWEL
Q3 2024 - Q2 revenue up 10.3% to $184.8M, China sales doubled, and dividend raised 11%.JWEL
Q2 2024 - Global expansion and innovation drive growth, targeting $1B+ revenue in 3-5 years.JWEL
Investor Day 2025 - Q1 2025 revenue up 14%, China up 52%, margins and guidance strong for the year.JWEL
Q1 2025 - Double-digit revenue and profit growth in 2024, with strong 2025 outlook led by China and international.JWEL
Q4 2024